» Articles » PMID: 15348319

Formation of Macropores in Calcium Phosphate Cement Implants

Overview
Publisher Springer
Date 2004 Sep 7
PMID 15348319
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

A calcium phosphate cement (CPC) was shown to harden at ambient temperatures and form hydroxyapatite as the only end-product. Animal study results showed that CPC resorbed slowly and was replaced by new bone. For some clinical applications, it would be desirable to have macropores built into the CPC implant to obtain a more rapid resorption and concomitant osseointegration of the implant. The present study investigated the feasibility of a new method for producing macropores in CPC. Sucrose granules, NaHCO3, and Na2HPO4 were sieved to obtain particle sizes in the range of 125 microm to 250 microm. The following mixtures of CPC powder (an equimolar mixture of tetracalcium phosphate, Ca4(PO4)2O, and dicalcium phosphate anhydrous, CaHPO4) and one of the above additive granules were prepared: control-no additive; mixture A-0.25 mass fraction of sucrose; mixture B-0.25 mass fraction of NaHCO3; mixture C-0.25 mass fraction of Na2HPO4, and mixture D-0.33 mass fraction of Na2HPO4. Cement samples were prepared by mixing 0.3 g of the above mixtures with 0.075 ml of the cement liquid (1 mol/l Na2HPO4). After hardening, the specimens were placed in water for 20 h at about 60 degrees C to completely dissolve the additive crystals. Well-formed macropores in the shapes of the entrapped crystals were observed by scanning electron microscope (SEM). The macroporosities (mean+/-standard deviation; n = 6) expressed as volume fraction in % were 0, 18.9 +/- 1.7, 26.9 +/- 1.6, 38.3 +/- 4.4 and 50.3 +/- 2.7 for the control, A, B, C and D, respectively. The diametral tensile strengths (mean+/-standard deviation; n = 3) expressed in MPa were 10.1 +/- 0.7, 3.7 +/- 0.3, 2.4 +/- 0.2, 1.5 +/- 0.5 and 0.4 +/- 0.1, respectively, for the five groups. The results showed that macropores can readily be formed in CPC implants with the use of water-soluble crystals. The mechanical strength of CPC decreased with increasing macroporosity.

Citing Articles

Moldable self-setting and bioactive bone wax for bone hemostasis and defect repair.

Liu Z, Liu C, Zhou H, Liang C, Chen W, Bai Y J Orthop Translat. 2025; 50:223-234.

PMID: 39895869 PMC: 11786162. DOI: 10.1016/j.jot.2024.11.009.


Calcium Phosphate Cements as Carriers of Functional Substances for the Treatment of Bone Tissue.

Lukina Y, Safronova T, Smolentsev D, Toshev O Materials (Basel). 2023; 16(11).

PMID: 37297151 PMC: 10254876. DOI: 10.3390/ma16114017.


3D models of dilated cardiomyopathy: Shaping the chemical, physical and topographical properties of biomaterials to mimic the cardiac extracellular matrix.

Camman M, Joanne P, Agbulut O, Helary C Bioact Mater. 2021; 7:275-291.

PMID: 34466733 PMC: 8379361. DOI: 10.1016/j.bioactmat.2021.05.040.


Characterization and Evaluations of Injectable Calcium Phosphate Cement Doped with Magnesium and Strontium.

Arkin V, NarendraKumar U, Madhyastha H, Manjubala I ACS Omega. 2021; 6(4):2477-2486.

PMID: 33553866 PMC: 7859950. DOI: 10.1021/acsomega.0c03927.


Development prospects of curable osteoplastic materials in dentistry and maxillofacial surgery.

Vasilyev A, Kuznetsova V, Bukharova T, Grigoriev T, Zagoskin Y, Korolenkova M Heliyon. 2020; 6(8):e04686.

PMID: 32817899 PMC: 7424217. DOI: 10.1016/j.heliyon.2020.e04686.


References
1.
Mirtchi A, Lemaitre J, Terao N . Calcium phosphate cements: study of the beta-tricalcium phosphate--monocalcium phosphate system. Biomaterials. 1989; 10(7):475-80. DOI: 10.1016/0142-9612(89)90089-6. View

2.
Sugawara A, Nishiyama M, Kusama K, Moro I, Nishimura S, Kudo I . Histopathological reactions of calcium phosphate cement. Dent Mater J. 1992; 11(1):11-6. DOI: 10.4012/dmj.11.11. View

3.
Ginebra M, Fernandez E, De Maeyer E, Verbeeck R, Boltong M, Ginebra J . Setting reaction and hardening of an apatitic calcium phosphate cement. J Dent Res. 1997; 76(4):905-12. DOI: 10.1177/00220345970760041201. View

4.
Cook S, Thongpreda N, Anderson R, Thomas K, HADDAD Jr R, GRIFFIN C . Optimum pore size for bone cement fixation. Clin Orthop Relat Res. 1987; (223):296-302. View

5.
Friedman C, Costantino P, Takagi S, Chow L . BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res. 1998; 43(4):428-32. DOI: 10.1002/(sici)1097-4636(199824)43:4<428::aid-jbm10>3.0.co;2-0. View